OI
GILD icon

Oakbrook Investments’s Gilead Sciences GILD Stock Holding History

Oakbrook Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-24,350
Closed -$1.58M – 263
2019
Q4 		$1.58M Sell
24,350
-11,050
-31% -$720K 0.32% 51
2019
Q3 		$2.24M Sell
35,400
-7,950
-18% -$520K 0.15% 96
2019
Q2 		$2.93M Sell
43,350
-32,390
-43% -$2.13M 0.18% 81
2019
Q1 		$4.92M Sell
75,740
-1,400
-2% -$93.1K 0.3% 57
2018
Q4 		$4.83M Buy
77,140
+6,070
+9% +$424K 0.33% 56
2018
Q3 		$5.49M Sell
71,070
-310,404
-81% -$23.4M 0.3% 56
2018
Q2 		$27M Sell
381,474
-3,665
-1% -$259K 1.71% 19
2018
Q1 		$29M Buy
385,139
+6,690
+2% +$532K 1.8% 16
2017
Q4 		$27.1M Sell
378,449
-5,645
-1% -$429K 1.72% 17
2017
Q3 		$31.1M Buy
384,094
+3,621
+1% +$277K 2.01% 10
2017
Q2 		$26.9M Sell
380,473
-5,705
-1% -$380K 1.79% 16
2017
Q1 		$26.2M Sell
386,178
-5,520
-1% -$388K 1.71% 12
2016
Q4 		$28M Sell
391,698
-4,937
-1% -$367K 1.83% 9
2016
Q3 		$31.4M Buy
396,635
+6,195
+2% +$503K 1.92% 8
2016
Q2 		$32.6M Buy
390,440
+53,370
+16% +$4.74M 1.8% 7
2016
Q1 		$31M Buy
337,070
+175,605
+109% +$15.8M 1.99% 7
2015
Q4 		$16.3M Buy
161,465
+42,515
+36% +$4.42M 1.04% 26
2015
Q3 		$11.7M Buy
118,950
+81,225
+215% +$9.02M 0.77% 35
2015
Q2 		$4.42M Sell
37,725
-4,325
-10% -$473K 0.27% 76
2015
Q1 		$4.13M Sell
42,050
-1,225
-3% -$124K 0.22% 107
2014
Q4 		$4.08M Sell
43,275
-8,325
-16% -$861K 0.22% 105
2014
Q3 		$5.49M Buy
51,600
+5,000
+11% +$490K 0.3% 82
2014
Q2 		$3.86M Buy
46,600
+3,500
+8% +$272K 0.12% 189
2014
Q1 		$3.05M Sell
43,100
-18,600
-30% -$1.46M 0.1% 216
2013
Q4 		$4.63M Buy
61,700
+5,550
+10% +$386K 0.13% 181
2013
Q3 		$3.53M Buy
56,150
+6,950
+14% +$415K 0.1% 208
2013
Q2 		$2.52M Buy
+49,200
New +$2.56M 0.07% 267

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Oakbrook Investments's GILD Position: Q1 2020 in Review

Oakbrook Investments sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 24,350 shares — an estimated $1.58M sold.

Oakbrook Investments first reported a position in GILD in Q2 2013 and held it in 27 quarters. The position peaked at $32.6M in Q2 2016. 1,642 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Oakbrook Investments reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 24,350 Gilead Sciences shares in Q1 2020, an estimated $1.58M.
  • Oakbrook Investments first reported a position in Gilead Sciences in Q2 2013 and held it in 27 quarters.
  • Oakbrook Investments's Gilead Sciences position peaked at $32.6M in Q2 2016.
  • 1,642 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.